Stock SCNI SCINAI IMMUNOTHERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Scinai Immunotherapeutics Ltd.

Equities

SCNI

US09073Q2049

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-02 EDT 		5-day change 1st Jan Change
0.4606 USD +4.77% Intraday chart for Scinai Immunotherapeutics Ltd. +2.36% -22.64%
04-08 Exchange-Traded Funds, Equity Futures Gain Slightly Pre-Bell Monday as June Rate Cut Likelihood Falls MT
04-08 Ayana Pharma Selects Scinai Immunotherapeutics' CDMO Unit to Provide Drug Development and cGMP Manufacturing Services CI

Evolution of the average Target Price on Scinai Immunotherapeutics Ltd.

Price target over the last 5 years

History of analyst recommendation changes

a939b2418a7fee6f71560abbf378e._IdjaUK43wJMv1o_AZsAHrCqBsAEWrhGz6ILA9jAXpg.vswpEA_nmWQn7QV9ZKIzVdWfVJFLd_00_OZfWuyvLsmU_zlcdImTcQfbEw~ba1086dac2644b8018e4c2c7d34e9669

Analyst Recommendations on Scinai Immunotherapeutics Ltd.

Aegis Capital Reinstates Coverage on BiondVax Pharmaceuticals With Buy Rating, $7 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4396 USD
Average target price
70 USD
Spread / Average Target
+15,823.57%
High Price Target
70 USD
Spread / Highest target
+15,823.57%
Low Price Target
70 USD
Spread / Lowest Target
+15,823.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Scinai Immunotherapeutics Ltd.

Aegis Capital

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SCNI Stock
  4. Consensus Scinai Immunotherapeutics Ltd.